Patents by Inventor Ib Groth Clausen

Ib Groth Clausen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6020180
    Abstract: A DNA sequence encoding a lipase having the amino acid sequence shown in SEQ ID NO:2. The lipase has a trypsin-like catalytic triad including an active serine located in a predominantly hydrophobic, elongated binding pocket of the lipase molecule and, located in a critical position of a lipid contact zone of the lipase structure, an amino acid residue different from an aromatic amino acid residue, which amino acid residue interacts with a lipid substrate at or during hydrolysis, in which lipase variant of the amino acid residue has been replaced by an aromatic amino acid residue so as to confer to the variant an increased specific activity as compared to that of the parent lipase.
    Type: Grant
    Filed: July 8, 1998
    Date of Patent: February 1, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Allan Svendsen, Shamkant Anant Patkar, Michi Egel-Mitani, Kim Borch, Ib Groth Clausen, Mogens Trier Hansen
  • Patent number: 5976855
    Abstract: The present invention relates to a method of preparing a variant of a parent lipolytic enzyme, comprising (a) subjecting a DNA sequence encoding the parent lipolytic enzyme to random mutagenesis, (b) expressing the mutated DNA sequence obtained in step (a) in a host cell, and (c) screening for host cells expressing a mutated lipolytic enzyme which has a decreased dependance to calcium and/or an improved tolerance towards a detergent or a detergent component as compared to the parent lipolytic enzyme.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: November 2, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Allan Svendsen, Ib Groth Clausen, Jens Sigurd Okkels, Marianne Thellersen
  • Patent number: 5914306
    Abstract: This invention relates to novel stabilized enzymes. More specifically the invention relates to novel stabilized enzymes, in which a naturally occurring amino acid residue (other than proline) has been substituted with a proline residue at one or more positions; at which position(s) the dihedral angles .phi. (phi) constitute values within the interval ?-90.degree.<.phi.<-40.degree.!; preferably the dihedral angles .phi. (phi) and .psi. (psi) constitute values within the intervals ?-90.degree.<.psi.<-40.degree.! and ?-180.degree.<.psi.<-150.degree. or -80<$g c)<10 or 100<.psi.<180!; and which positions(s) is/are not located in regions in which the enzyme is characterized by possessing .alpha.-helical or .beta.-sheet structure. The invention also relates to nucleotide sequences encoding the novel stabilized enzymes, and expression vectors and host organisms containing the nucleotide sequences. This invention also relates to detergent compositions comprising the stabilized enzymes.
    Type: Grant
    Filed: October 22, 1993
    Date of Patent: June 22, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Allan Svendsen, Claus von der Osten, Ib Groth Clausen, Shamkant Anant Patkar, Kim Borch
  • Patent number: 5892013
    Abstract: The present invention relates to lipase variants which exhibit improved properties, detergent compositions comprising said lipase variants, DNA constructs coding for said lipase variants, and methods of making said lipase variants.
    Type: Grant
    Filed: September 5, 1995
    Date of Patent: April 6, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Allan Svendsen, Shamkant Anant Patkar, Erik Gormsen, Ib Groth Clausen, Jens Sigurd Okkels, Marianne Thellersen
  • Patent number: 5753487
    Abstract: This invention relates to stabilization of phenylalanine ammonia lyase against proteolytic degradation by chemical modification with crosslinking agents, or by genetic modification, a phenylalanine ammonia lyase variant, a method of preparing the variant and a pharmaceutical composition containing phenylalanine ammonia lyase.
    Type: Grant
    Filed: December 12, 1995
    Date of Patent: May 19, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Peter Eigtved, Ib Groth Clausen
  • Patent number: 5674833
    Abstract: A detergent composition and additive comprising a protease and a reversible protease inhibitor of the peptide or protein type, wherein the ratio of the dissociation constant to the protease concentration in the range from 0.006 to 6. When the protease is subtilisin, the protease inhibitor is preferably a modified subtilisin inhibitor of Family VI.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: October 7, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Jan M.o slashed.ller Mikkelsen, Allan Svendsen, B.o slashed.rge Diderichsen, Ib Groth Clausen